When NAD+ enhancement with NR in NAFLD patients and animal models, elevated plasma levels of Fndc5/irisin were observed in both mice and humans, along with increased expression of Fndc5 in skeletal muscle, adipose, and hepatic tissues in mice. Here, FNDC5 is linked to metabolic dysfunction-associated steatotic liver disease.